Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 40.01 | 43.11 | 54.35 | 40.70 | 44.70 | 45.97 | 64.81 | 40.34 | 44.45 | 52.00 | 65.49 | 43.56 |
| Expenses | 39.00 | 40.58 | 49.70 | 40.23 | 42.16 | 46.67 | 59.51 | 38.88 | 44.09 | 47.92 | 59.79 | 39.01 |
| Operating Profit | 1.01 | 2.53 | 4.65 | 0.47 | 2.54 | -0.70 | 5.30 | 1.46 | 0.36 | 4.08 | 5.70 | 4.55 |
| OPM % | 2.52% | 5.87% | 8.56% | 1.15% | 5.68% | -1.52% | 8.18% | 3.62% | 0.81% | 7.85% | 8.70% | 10.45% |
| Other Income | 2.85 | 1.63 | 4.79 | 2.30 | 2.80 | 5.76 | -5.37 | 8.36 | 1.62 | 1.94 | 3.02 | 2.46 |
| Interest | 0.92 | 0.99 | 0.90 | 0.95 | 1.22 | 1.14 | 0.96 | 1.01 | 0.96 | 0.70 | 1.42 | 0.98 |
| Depreciation | 1.14 | 1.13 | 0.25 | 0.98 | 1.01 | 0.99 | 1.02 | 0.88 | 1.06 | 0.96 | 1.05 | 1.35 |
| Profit before tax | 1.80 | 2.04 | 8.29 | 0.84 | 3.11 | 2.93 | -2.05 | 7.93 | -0.04 | 4.36 | 6.25 | 4.68 |
| Tax % | 40.00% | 34.31% | -8.69% | 59.52% | 15.76% | 23.89% | -86.83% | -3.66% | 1,300.00% | 16.51% | -4.00% | 14.96% |
| Net Profit | 1.08 | 1.33 | 9.02 | 0.35 | 2.62 | 2.23 | -0.27 | 8.22 | -0.56 | 3.64 | 6.50 | 3.98 |
| EPS in Rs | 0.14 | 0.17 | 1.18 | 0.05 | 0.34 | 0.29 | -0.04 | 1.07 | -0.07 | 0.47 | 0.85 | 0.52 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 132 | 134 | 125 | 150 | 133 | 163 | 197 | 170 | 173 | 196 | 202 | 206 |
| Expenses | 145 | 137 | 137 | 144 | 136 | 165 | 171 | 162 | 167 | 187 | 190 | 191 |
| Operating Profit | -13 | -3 | -12 | 6 | -3 | -2 | 25 | 8 | 6 | 9 | 12 | 15 |
| OPM % | -10% | -2.1% | -9% | 3.9% | -2.5% | -0.9% | 13% | 5.0% | 3.4% | 4.6% | 6% | 7% |
| Other Income | 95 | -2 | 25 | 8 | 24 | 40 | 33 | 12 | 10 | 5 | 15 | 9 |
| Interest | 4 | 5 | 3 | 3 | 4 | 3 | 2 | 3 | 6 | 5 | 4 | 4 |
| Depreciation | 17 | 4 | 2 | 2 | 3 | 2 | 2 | 3 | 4 | 4 | 4 | 4 |
| Profit before tax | 62 | -14 | 8 | 8 | 15 | 33 | 54 | 15 | 7 | 5 | 19 | 15 |
| Tax % | 22% | 34% | 84% | 48% | 6% | 10% | 13% | 25% | 15% | -2% | 4% | |
| Net Profit | 48 | -18 | 1 | 4 | 14 | 29 | 47 | 11 | 6 | 5 | 18 | 14 |
| EPS in Rs | 6.28 | -2.38 | 0.17 | 0.55 | 1.83 | 3.83 | 6.16 | 1.49 | 0.74 | 0.64 | 2.32 | 1.77 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 4% | 4% | 6% | 5% | ||
| Compounded Profit Growth | 10% | 10% | 17% | -24% | ||
| Stock Price CAGR | 20% | 5% | -2% | 17% | ||
| Return on Equity | 11% | 13% | 8% | 12% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 | 77 |
| Reserves | -86 | -38 | -51 | -50 | -46 | -32 | -3 | 43 | 54 | 60 | 63 | 82 |
| Borrowings | 46 | 47 | 42 | 43 | 40 | 31 | 28 | 27 | 45 | 46 | 51 | 57 |
| Other Liabilities | 132 | 94 | 93 | 128 | 144 | 111 | 108 | 84 | 70 | 67 | 79 | 65 |
| Total Liabilities | 169 | 180 | 160 | 197 | 214 | 186 | 210 | 231 | 246 | 250 | 270 | 280 |
| Fixed Assets | 91 | 72 | 72 | 59 | 58 | 57 | 57 | 58 | 85 | 88 | 87 | 89 |
| CWIP | 1 | 9 | 3 | 14 | 24 | 0 | 1 | 12 | 4 | 0 | 0 | 4 |
| Investments | 1 | 8 | 5 | 5 | 9 | 18 | 27 | 33 | 32 | 29 | 32 | 32 |
| Other Assets | 76 | 92 | 80 | 119 | 123 | 110 | 125 | 128 | 125 | 133 | 151 | 155 |
| Total Assets | 169 | 180 | 160 | 197 | 214 | 186 | 210 | 231 | 246 | 250 | 270 | 280 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -8 | -75 | 5 | -7 | 19 | -7 | -2 | 11 | 6 | 9 | -18 | 13 |
| Cash from Investing Activity | 10 | 80 | -3 | 18 | -9 | 17 | 10 | 5 | -17 | -5 | 13 | -10 |
| Cash from Financing Activity | -1 | -3 | -6 | -2 | -6 | -14 | -6 | -19 | 9 | -3 | -2 | -2 |
| Net Cash Flow | 1 | 2 | -4 | 8 | 3 | -4 | 2 | -3 | -2 | 1 | -6 | 1 |
| Free Cash Flow | 1 | 12 | 1 | 8 | 9 | -10 | 7 | 16 | -15 | 6 | -20 | 7 |
| CFO/OP | 90% | 551% | -252% | -107% | 453% | 134% | 22% | 60% | 120% | 217% | -160% | 107% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74 | 83 | 79 | 100 | 84 | 79 | 87 | 52 | 59 | 55 | 82 | 86 |
| Inventory Days | 86 | 72 | 66 | 75 | 61 | 76 | 58 | 48 | 62 | 58 | 75 | 68 |
| Days Payable | 139 | 135 | 138 | 207 | 191 | 184 | 184 | 151 | 131 | 133 | 158 | 125 |
| Cash Conversion Cycle | 22 | 20 | 6 | -32 | -46 | -29 | -39 | -50 | -10 | -19 | -2 | 30 |
| Working Capital Days | -318 | -156 | -185 | -187 | -190 | -140 | -88 | -25 | -43 | -35 | -25 | 13 |
| ROCE % | -19% | -44% | -1% | -5% | 16% | 25% | 18% | 34% | 11% | 7% | 9% | 12% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 30.78% | 30.78% | 30.78% | 30.78% | 31.35% | 31.35% | 31.35% | 31.35% | 31.35% | 31.36% | 31.36% | 31.36% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.38% | 0.38% | 0.34% | 0.34% | 0.00% | 0.00% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.10% | 0.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 69.23% | 69.21% | 69.23% | 69.22% | 68.65% | 68.54% | 68.18% | 68.26% | 68.32% | 68.29% | 68.64% | 68.64% |
| No. of Shareholders | 1,75,222 | 1,71,944 | 1,70,079 | 1,69,228 | 1,72,338 | 1,71,221 | 1,70,912 | 1,69,630 | 1,70,015 | 1,68,396 | 1,67,599 | 1,67,066 |
Fundamentals
Market Cap₹ 300 Cr.
Current Price₹ 39.0
Stock P/E21.1
Book Value₹ 20.7
ROCE11.7 %
ROE12.4 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)5%
Compounded Profit Growth (TTM)-24%
Consolidated figures.
Valuation
Market capRs 290 Cr
Enterprise valueRs 327 Cr
P/E (TTM)21.41x
Price to book1.83x
Price to sales1.41x
EV / EBITDA13.80x
EV / EBIT16.96x
EV / sales1.59x
Price to cash flow21.67x
Earnings yield4.67%
P/E, 3-year average42.10x
P/B, 3-year average1.88x
P/E, 5-year average29.14x
P/B, 5-year average1.82x
Profitability
Operating margin (excl. other income)6.00%
Operating margin (incl. other income)13.31%
EBITDA margin11.55%
Pre-tax margin7.42%
Net profit margin6.60%
Net margin, latest quarter9.14%
ROE11.93%
ROCE11.32%
ROA6.48%
ROE, 3-year average6.58%
ROCE, 3-year average7.86%
ROA, 3-year average3.56%
ROE, 5-year average15.53%
ROCE, 5-year average15.99%
ROA, 5-year average7.38%
ROIC (approx.)9.50%
Tax rate3.84%
Other income / net worth9.33%
Growth
Sales growth (latest year)3.10%
Profit growth (latest year)261.05%
Sales CAGR, 3 years5.90%
Sales CAGR, 5 years4.35%
Profit CAGR, 3 years15.84%
Profit CAGR, 5 years-9.52%
Sales growth QoQ-33.49%
Profit growth QoQ-38.77%
Sales growth YoY (latest quarter)7.98%
Profit growth YoY (latest quarter)-51.58%
Per share
EPS (TTM)Rs 1.77
EPS (latest year)Rs 2.32
EPS (latest quarter)Rs 0.52
EPS, 3-year averageRs 1.24
EPS, 5-year averageRs 2.27
Book value per shareRs 20.66
Sales per shareRs 26.82
Cash flow per shareRs 1.75
Free cash flow per shareRs 0.91
Efficiency
Asset turnover0.72x
Fixed asset turnover2.27x
Inventory turnover6.14x
Inventory days59 days
Debtor days86 days
Debtors turnover4.24x
Creditor days125 days
Cash conversion cycle30 days
Working capital days13 days
Leverage
Total debtRs 57 Cr
Cash and bankRs 19 Cr
Net debtRs 37 Cr
Debt to equity0.36x
Net debt / EBITDA1.56x
Interest coverage4.76x
Owners' fund to total sources56.65%
Debt to assets20.22%
Cash flow
Cash from Operating Activity (latest year)Rs 13 Cr
Cash from Investing Activity (latest year)Rs -10 Cr
Cash from Financing Activity (latest year)Rs -2 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs 7 Cr
FCFE (approx.: FCF + change in debt)Rs 13 Cr
Cash from ops / profit, 5 years0.24x
Sales to cash flow15.08x
Statement figures
Net sales (TTM)Rs 206 Cr
Net sales (latest year)Rs 202 Cr
Sales (latest quarter)Rs 44 Cr
Operating profit excl. other income (latest year)Rs 12 Cr
Operating profit (latest quarter)Rs 5 Cr
Other income (TTM)Rs 9 Cr
EBITDA (TTM)Rs 24 Cr
PBDT (TTM)Rs 20 Cr
Profit before tax (TTM)Rs 15 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs 14 Cr
Net profit (latest year)Rs 18 Cr
Net profit (latest quarter)Rs 4 Cr
Depreciation (TTM)Rs 4 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 4 Cr
Cost of goods sold (latest year)Rs 137 Cr
Total expenditure (latest year)Rs 190 Cr
Total income (latest year)Rs 217 Cr
Share capitalRs 77 Cr
ReservesRs 82 Cr
Shareholders' fundsRs 158 Cr
Total assetsRs 280 Cr
Net blockRs 89 Cr
Capital work in progressRs 4 Cr
InvestmentsRs 32 Cr
ReceivablesRs 48 Cr
InventoryRs 22 Cr
Other liabilitiesRs 65 Cr
Shares outstanding (crore)7.66
Ownership
Promoter holding31.36% (+0.01 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 21.4 is at the 52th percentile of its own 8.4-year range
(median 20.1, low 3.3, high 92.7).
P/B 1.83 is at the 18th percentile (median 2.98).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | AMBALALSA | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -8.2% | -2.8% | -5.4 pts |
| 1 month | -13.7% | -6.8% | -6.9 pts |
| 3 months | +15.4% | -7.6% | +23.1 pts |
| 3 years | -9.4% | +14.2% | -23.6 pts |
| 5 years | +23.6% | +27.9% | -4.3 pts |
Red flags
F-score 5 of 8| explain | Weak cash conversion Cash from operations was 16% of net profit over the last 3 years |
| look | Profit leans on other income Other income was 80% of pre-tax profit in 2026 |
| look | On NSE surveillance On NSE surveillance: ESM |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹44 Cr +8.0% vs Jun 2025.
Net profit ₹4 Cr -51.6%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
ESM: stage 1